Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS

Study Overview
=================
Brief Summary
-----------------
This community-engaged research project will test an adapted online breast cancer screening decision aid to address the needs of women living in an area where environmental contamination has increased concern about breast cancer risk. It will provide novel data on individual experiences with breast cancer risk assessment and decisional determinants of screening choices in a community disproportionately impacted by industrial pollution.

Detailed Description
-----------------
Environmental contamination is increasingly recognized as a critical driver of cancer disparities, and communities impacted by industrial pollution experience greater risk of cancer and higher cancer worry which complicates health decision making. Recently the National Academies of Science Engineering and Medicine (NASEM) released guidance suggesting that per- and polyfluoroalkyl substances (PFAS) are suggestively associated with breast cancer risk and that individuals with moderate to high blood concentrations of these chemicals should screen for breast cancer according to age and other risk factors as recommended by the US Preventive Services Task Force (USPSTF). Mammography screening guidelines for women in their 40s increasingly call for the use of risk assessment tools to guide screening initiation and imaging intervals (e.g. every year vs. every two years), but current tools do not address environmental risk factors that can contribute to breast cancer risk. This poses a particular challenge in communities where there is a real or perceived increased risk of breast cancer stemming from an environmental contamination concern. There are currently no decision tools tailored to help women living in such communities with their decisions about breast cancer screening. Therefore, the goal of the proposed work is to test an adapted online decision aid to incorporate environmental risk messaging to increase informed breast cancer screening decisions for women 40-49 years of age living in the greater Merrimack, New Hampshire area, where known and ongoing PFAS contamination exists. In partnership with Merrimack Citizens for Clean Water, we will distribute a community survey among screening-eligible women to test the new risk messaging within the decision aid (n=100) and establish acceptability in an open-label, single arm trial. The proposed research will contribute novel data on community-driven priorities for information about environmental contaminants that may affect breast cancer risk assessment and screening decisions.

Official Title
-----------------
Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by Per- and Polyfluoroalkyl Substances (PFAS)

Conditions
-----------------
Breast Cancer Screening

Intervention / Treatment
-----------------
* Behavioral: MyMammogram decision aid


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Females aged 40-49 No personal history of breast cancer, No mammogram in the prior 12 months Resident of Hillsborough County, New Hampshire for at least 5 years (since 2018) Exclusion Criteria: History of breast cancer, ductal carcinoma in situ, lobular carcinoma in situ Cognitive impairment impeding the ability to provide informed consent

Ages Eligible for Study
-----------------
Minimum Age: 40 Years
Maximum Age: 49 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Decision Aid<br>Participants will receive the adapted MyMammogram decision aid that includes environmental risk information. | Behavioral: MyMammogram decision aid<br>* An online breast cancer screening decision aid that includes personalized risk assessment, information on benefits and risks of mammography screening, values clarification, outcome expectancies, and a summative document with participant responses.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Acceptability | Acceptability e-scale,72 a 6-item measure for electronically-delivered interventions | Within 1 day, post-intervention | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Knowledge | 10 Knowledge items summed to measure understanding of clinical screening, alternatives, main benefits/risks | Immediately pre-intervention, within 1 day post-intervention | 
| Decisional Conflict | The SURE measure, a 4-item validated checklist to assess decisional conflict, including benefits and risks of test | Immediately pre-intervention, within 1 day post-intervention | 
| Screening self-efficacy | 10-item validated scale measuring self efficacy in obtaining mammography with summed score, range 5-50 | Immediately pre-intervention, within 1 day post-intervention | 
| Screening Intentions | 15-point validated scale measuring intentions and 1 decision question (yes/no/unsure) | Immediately pre-intervention, within 1 day post-intervention | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
per- and polyfluoroalkyl substances, breast cancer screening, decision aid, risk assessment